Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease systemic scleroderma
Symptom C0034735|raynaud\'s phenomenon
Sentences 13
PubMedID- 26016221 Secondary raynaud's phenomenon is common with rheumatic diseases (systemic sclerosis, systemic lupus erythematosus, primary sjogren's syndrome, mixed connective tissue disease, etc.), occlusive vascular diseases, hematologic disorders, use of vibrating tools and use of some medications, and rarely with malignancy.
PubMedID- 22204894 Botulinum toxin type a contribution in the treatment of raynaud's phenomenon due to systemic sclerosis.
PubMedID- 24744785 It has also been shown to be effective in treating severe raynaud's phenomenon associated with systemic sclerosis and digital ulceration.
PubMedID- 21888685 Microvascular disease is a prominent feature of systemic sclerosis (ssc) and leads to raynaud's phenomenon, pulmonary arterial hypertension, and scleroderma renal crisis.
PubMedID- 24705032 Efficacy of bosentan in the treatment of raynaud's phenomenon in patients with systemic sclerosis never treated with prostanoids.
PubMedID- 21151540 The main clinical differential diagnoses are sclerodermiform diseases including systemic sclerosis with raynaud's phenomenon, calcinosis, megacapillary, a specific pattern in capillary microscopy, and antinuclear antibodies, as well as toxic oil syndrome and eosinophilia-myalgia syndrome due to l-tryptophan intake 5.
PubMedID- 25015229 Case presentation: we report two cases (a 64-year-old japanese woman and a 69-year old japanese woman) of systemic sclerosis, both with severe raynaud's phenomenon and pulmonary arterial hypertension.
PubMedID- 24268960 Vascular involvement of the hands is at the forefront of systemic sclerosis, with raynaud's phenomenon, which may be complicated by digital ulcers, digital necrosis causing pain, infection and significant disability.
PubMedID- 26088182 Efficacy of cilostazol for the treatment of raynaud's phenomenon in systemic sclerosis patients.
PubMedID- 26421308 The presence of giant capillaries is the earliest and most striking sign of secondary raynaud's phenomenon due to systemic sclerosis (ssc) .
PubMedID- 23934522 The value of pattern capillary changes and antibodies to predict the development of systemic sclerosis in patients with primary raynaud's phenomenon.
PubMedID- 24082191 1 systemic sclerosis with history of raynaud's phenomenon and nail fold bleeding with underlying uterine carcinoma has been reported.
PubMedID- 25461837 In the last few years, a number of studies have been published on a condition characterized by raynaud's phenomenon (rp) associated with systemic sclerosis (ssc) marker autoantibodies and/or scleroderma-type capillaroscopic abnormalities and referred to as very early/early ssc.

Page: 1